Endophthalmitis most often caused by Staphylococcus

Article

Endophthalmitis is most often caused by coagulase-negative Staphylococcus, and the antibiotics vancomycin and ceftazidime seem to perform well in treating it. That was one of the findings of a 25-year retrospective study conducted by Dr Ronald C. Gentile, of the New York Eye and Ear Infirmary, and his colleagues in New York City and San Antonio, Texas, USA.

Endophthalmitis is most often caused by coagulase-negative Staphylococcus, and the antibiotics vancomycin and ceftazidime seem to perform well in treating it.

That was one of the findings of a 25-year retrospective study conducted by Dr Ronald C. Gentile, of the New York Eye and Ear Infirmary, and his colleagues in New York City and San Antonio, Texas, USA. The researchers set out to look for trends related to pathogens and antibiotics over the past 25 years. They reported their results in Ophthalmology.

Other findings:

  • Many antibiotics, among them cephalosporins and methicillin, are associated with a statistically significant trend in increasing microbial resistance.
  • A significant trend toward decreasing microbial resistance against aminoglycosides and imipenem also exists.

The researchers studied 911 eyes with a total of 988 consecutive culture-positive endophthalmitis isolates that had been collected from 1987 to 2011. The pathogens they most frequently found were coagulase-negative Staphylococcus (39.4%), Streptococcus viridans species (12.1%) and Staphylococcus aureus (11.1%). Gram-negative organisms accounted for 10.3% of all isolates and fungi accounted for 4.6% of them.

Two isolates, Enterococcus faecium and Nocardia exalbida, were not susceptible to vancomycin, but the rest of the 725 gram-positive bacteria they tested were susceptible. The researchers tested 94 gram-negative organisms against ceftazidime and found that 2 were of intermediate sensitivity and 6 were resistant.

The researchers found that microbial resistance was associated with 8 antibiotics as time went on. Those 8 were ampicillin, cefazolin, cefotetan, ceftriaxone, cephalothin, clindamycin, erythromycin and methicillin/oxacillin. They saw increasing microbial susceptibility with 3 antibiotics: gentamicin, imipenem and tobramycin.

To read the abstract of the study click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.